This site is intended for healthcare professionals
UCARE podcast logo
All Things Angioedema and Urticaria: Podcasts
Declaration of sponsorship GA²LEN UCARE/ACARE

Test video

Declaration of sponsorship GA²LEN UCARE/ACARE
Last updated:1st Apr 2024
Published:28th Feb 2024

This demonstrations show content surfacing if the user has watched 50% or more of the video

CRUSE CONTROL: A chronic urticaria self-evaluation app

Episode 35 – Dr Sophia Neisinger introduces the CRUSE CONTROL app, which has been developed to help support CSU self-evaluation and aims to improve patient quality of life.

Urticaria and the CRUSE app

Episode 66 – Professor Marcus Maurer is joined by Dr Aistė Ramanauskaitė to explore the CRUSE app's potential advantages for individuals with CSU. Professor Maurer emphasises the importance and utilisation of the CRUSE app, while Dr Ramanauskaitė delves into the various benefits and practical applications offered by the app.

Apps, refugees, and the future of digital healthcare

Episode 79 – “This is only the beginning of making use of this technology.” Professor Marcus Maurer is joined by asthma and allergic rhinitis expert Professor Jean Bousquet to discuss the collaboration that produced the MASK-Air and CRUSE apps, how they are helping Ukrainian refugees and the possibilities for future development.

Are you CSU aware?

Episode 36 – Professor Marcus Maurer is joined by Dr Christian Vestergaard, who offers expert insight into the results of the AWARE study and highlights the urgent need for wider dissemination of the guidelines for CSU management.

Updates from AAAAI conference 2023

Episode 60 – Professor Marcus Maurer and Dr Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.

UCARE Conference 2023

Episode 81 – “It’s really a catalyst to what the network does.” Professor Marcus Maurer asks Dr Luis Felipe Ensina to reflect on the UCARE Conference 2023, covering personal highlights and expectations for future meetings.

Getting a grip on itch

Episode 2 – Itch can have a profound impact on quality of life in patients with urticaria Professor. Marcus Maurer is joined by itch expert, Professor Martin Metz, who explains that itch is much more than just “the little brother of pain” and describes the research that is currently underway to improve our understanding of this debilitating symptom.

Sweat it out

Episode 4 – In cholinergic urticaria, symptoms may arise as a result from any activity that induces sweating. Professor Marcus Maurer is joined by cholinergic urticaria expert Dr Sabine Altrichter, who provides insight into what is currently known about this debilitating condition.

Cold urticaria: The future is bright

Episode 5 – Cold urticaria expert, Dr Dorothea Terhorst-Molawi, and host, Professor Marcus Maurer, discuss the complexities of this highly heterogenous condition and explain why they are optimistic about what the future holds for those affected.

Mastocytosis, MCAS and beyond the skin in CSU

Episode 12 – Dr Frank Siebenhaar brings us up to date on the differences between mastocytosis, urticaria and mast cell activation syndrome (MCAS). He also introduces CSUplus, an ongoing UCARE project that aims to shed light on the extracutaneous symptoms of CSU.

Symptomatic dermographism

Episode 13 – Despite affecting up to 5% of the population, symptomatic dermographism remains understudied. Discover more about how our ability to diagnose and treat this common and debilitating condition is improving from urticaria expert, Dr Tomasz Hawro.

Exploring the CSU spectrum: Pure angioedema

Episode 16 – Did you know that not all patients with CSU develop wheals? Professor Connie Katelaris explains the unique challenges physicians face when diagnosing and managing people with CSU who have pure angioedema without wheals and offers advice on how to spot pseudoangioedema.

All things acute urticaria

Episode 17 – Did you know that around 20% of the population will experience acute urticaria sometime in their lifetime. Dr Angèle Soria explains the differences between acute urticaria and other urticarias, how to manage the condition, and what to look out for, and highlights her most recent publication.

Gender differences in CU

Episode 27 – It is well known that chronic urticaria (CU) is more common in women than men, but why is this the case? In this episode, expert guest Professor Laurence Bouillet explores gender-based differences in this disease.

The pathogenesis of CSU: When will we have a cure?

Episode 28 – Does our current understanding of the pathogenesis of CSU provide hope of a cure for this challenging disease? Find out what Dr Riccardo Asero has to say as he joins our host to discuss some of the most fundamental questions in the field of urticariology.

Shining a light on solar urticaria

Episode 30 – Photodermatology expert, Professor Lesley Rhodes, sheds light on one of the rarer forms of chronic inducible urticaria: solar urticaria. This includes a practical guide to diagnosis and referral, as well as a summary of the unmet needs that remain in the management of this understudied condition.

The role of PAF and urticaria in adults

Episode 31 – Dr Ana Gimenez discusses new insights into the pathology of CU and how these insights can help guide treatment decisions. Dr Gimenez discusses the inflammatory mediators relevant in CU, with a particular focus on platelet-activating factor (PAF). She describes the role of PAF, its contribution to the development of signs and symptoms of CU, and why she considers PAF an important consideration in CSU.

CU and systemic auto-inflammatory syndromes

Episode 47 – Dr Sinisa Savic joins Professor Marcus Maurer to discuss CU and systemic auto-inflammatory syndromes, delving into differential diagnostic techniques and utilisation of genetics to determine causation of clinical presentations.

Recurrent angioedema in CSU

Episode 53 – Professor Marcus Maurer is joined by Professor Asli Gelincik to discuss recurrent angioedema in CSU, and treatment options that are currently available to alleviate this pathology. The mechanistic actions of mast cell-mediated angioedema and bradykinin-mediated angioedema are discussed, and their implications are analysed.

Mast cell involvement in CSU

Episode 54 – Professor Yoshimichi Okayama joins Professor Marcus Maurer to discuss the role that mast cells play in the disease aetiology of CSU. In particular, the discussion focuses on mast cell receptors and how they can be utilised in the diagnosis of CSU.

Delayed pressure urticaria in the CSU landscape

Episode 55 – Professor Alicja Kasperska-Zajac joins Professor Marcus Maurer to discuss a rare form of chronic inducible urticaria – delayed pressure urticaria. The discussion highlights the difficulties in undertaking differential diagnosis and the main differences when compared with chronic spontaneous urticaria, namely the absence of oedema and wheals.

Gut microbiome and chronic spontaneous urticaria

Episode 56 – Dr Jie Li joins Professor Marcus Maurer to discuss the role of the gut microbiome in the disease progression of CSU. Particular focus is given to metabolism and homeostasis in people with CSU, how the gut microbiome can impact CSU presentation, and the impact it can have on the efficacy of treatments such as antihistamines.

Symptomatic dermographism in chronic urticaria

Episode 58 – Dr Melba Munoz joins Professor Marcus Maurer to take a deeper look at symptomatic dermographism. The pair discuss the involvement of mast cells in CSU and attempt to answer ongoing questions to help unravel the pathogenesis of dermographism in chronic urticaria.

Biomarkers in chronic urticaria

Episode 59 – Dr Murat Türk joins Professor Marcus Maurer to discuss biomarkers in CSU, focusing on immunoglobulin E (IgE). They emphasise the importance of using IgE testing appropriately, as a prognostic parameter rather than a diagnostic technique. The discussion expands into a comparison between basophil testing and IgE testing and explores the implications of these results for people with CSU.

IL-9, IL-10 and CSU pathogenesis

Episode 72 – Dermatologist Professor Kiran Godse joins Professor Marcus Maurer to explore the use of JAK and STAT inhibitors in the management of chronic urticaria and how these drugs may impact quality of life for people with this condition.

What is cold urticaria?

Episode 78 – “Wouldn’t it be nice to find a cure?” Professor Marcus Maurer is joined by Dr Aurélie Du-Thanh to discuss cold urticaria, covering risk factors, the diagnosis journey and the most suitable treatment options.

Managing autoimmune CSU 

Episode 82 – “There’s still so much we need to learn.” Dr João Marcelino joins Professor Marcus Maurer to discuss autoimmune chronic spontaneous urticaria, including indicative test results and hopes for the future. 

Improving patient care with PROMs

Episode 3 – Patient-reported outcome measures (PROMs) are used to assess disease activity, impact, and control in people with urticaria. Professor Marcus Maurer is joined by PROM expert Dr Karsten Weller who explains that, while such tools are essential to improve the management of urticaria, they can be challenging to develop.

Beating the burden of CU

Episode 7 – Professor Marcus Maurer is joined by ‘UCARE father’ Dr Luis Felipe Ensina to discuss the frequently underestimated burden of urticaria, which Dr Ensina explains is not limited to the patients themselves but may indirectly impact numerous friends and family members as well.

CU in pregnancy and COVID-CU

Episode 9 – Professor Marcus Maurer is joined by Professor Emek Kocatürk Göncü, who addresses concerns regarding the impact of COVID-19 infection in people with CU and summarises the results of the recent UCARE project, PREG-CU.

Let’s talk comorbidities

Episode 21 – How do comorbidities affect people with CSU, and what can be done to minimise their impact? Find out more on this crucial, yet understudied, topic from Dr Simon Francis Thomsen.

Improving sleep quality in urticaria: More than just a dream?

Episode 25 – Professor Marcus Maurer is joined by Dr Caroline Mann, an urticariologist and sleep expert, who highlights the profound impact of sleep disturbance on quality of life in people with urticaria and explains what can be done to address this common – but often overlooked – aspect of the disease.

Paediatric urticaria: Challenges and solutions

Episode 29 – Paediatric urticaria expert and UCARE driving force Professor Petra Staubach-Renz reflects on her experience of treating children with CU and calls for more research into this important yet understudied group of patients.

CU: A North American perspective

Episode 39 – Professor Jonathan Bernstein discusses CU care in the USA, including the challenges faced by US-based physicians, and highlights the potential benefits of conducting further research into the diverse population living with CU in North America.

CU: An Indian perspective

Episode 40 – Professor Marcus Maurer is joined by Professor Kiran Godse, who shares his experiences of treating CSU in India. Professor Godse provides insights into the practicalities of CSU care, including economic considerations, as well as his plans to increase the UCARE network’s presence in India and facilitate wider dissemination of educational resources.

CU: A Middle Eastern perspective

Episode 41 – Dr Mona Al-Ahmad, from the UCARE centre in Kuwait, shares her insights into the UCARE network’s Middle Eastern activities. Dr Al-Ahmad also reflects on what more can be done to improve the lives of people living with CU and those caring for them.

CU: A Latin American perspective

Episode 42 – Dr Maximiliano Gómez shares his tips and tricks for improving the diagnosis and management of CU, and calls for wider dissemination of quality information to patients living in Argentina and beyond.

CU: A South African perspective

Episode 43 – Associate Professor Jonathan Peter (University of Cape Town and University of Cape Town Lung Institute, South Africa) explains regional differences in urticaria in South Africa, with a focus on epidemiology, patient beliefs and education, and the CRUSE app.

All things urticaria: A Turkish perspective

Episode 45 – Perspective Professor Marcus Maurer is joined by Dr Murat Türk and Dr Ragıp Ertaş of UCARE in Turkey to discuss advances in the treatments of urticaria, with a special focus on the implementation of artificial intelligence and machine learning.

All things urticaria: A Chinese perspective

Episode 46 – During this episode, Professor Marcus Maurer is joined by Dr Zuotao Zhao of Beijing Medical University, China, to discuss the growing problem of chronic spontaneous urticaria within the Chinese population and delve into possible causes of such a high incidence.  

Psycho-neurodermatology in CU and mental health

Episode 49 – Professor Anna Zalewska-Janowska joins Professor Maurer to delve into fascinating area of psycho-neurodermatology and how this can impact the lives of individuals with urticaria. Professor Zalewska-Janowska highlights the importance of how urticaria is linked to neurogenic inflammation in CU.

Urticaria: A general practitioner’s perspective

Episode 64 – Professor Marcus Maurer is joined by GP Dr Dermot Ryan to discuss the role of GPs in the diagnosis and management of CU. Professor Maurer and Dr Ryan highlight the positive impact that physicians have in limiting patient distress while increasing patient confidence, despite the time-limited interactions. They also explore the impact of mistreatment on a patient’s life.

Angioedema and CSU

Episode 68 – Dr Régis de Albuquerque Campos joins Professor Marcus Maurer to discuss the implications of angioedema and its impact on people living with CSU. Dr Campos highlights diverse aspects of the burden of CSU and the impact misdiagnosis has on quality of life. Professor Maurer provides an overview of the current treatment landscape, differential diagnosis, unmet needs in angioedema clinical trials and the utilisation of omalizumab in managing angioedema associated with CSU.

The burdens of angioedema

Episode 69 – Professor Marcus Maurer is joined by Professor Paula Busse to explore the multifaceted burdens of angioedema for patients and physicians. They discuss issues surrounding timely diagnosis, interpreting ambiguous symptoms, patient concerns about medications, and enhancing quality of life monitoring.

Urticaria and stress

Episode 73 – Professor Marcus Maurer is joined by Professor Eduardo Souza Lima to explore the relationship between stress and urticaria, and the implications of mast cells and neuropeptides in CSU.

Urticaria in a veterinary setting

Episode 75 – In response to listener requests, Professor Marcus Maurer is joined by veterinary specialist Professor Ralf Mueller to discuss how urticaria affects animals, including similarities and differences with the condition in humans and the challenges of treating performance animals.

Clinical nurse specialists: Leading collaborative care

Episode 76 – Professor Marcus Maurer is joined by Clinical Nurse Specialist Lorena Lorenzo to discuss the responsibilities of the nurse’s role, and the potential benefits it brings for people living with urticaria.

CU: A Hong Kong perspective

Episode 86 – Professor Marcus Maurer welcomes Professor Philip Li to discuss the management of urticaria in Hong Kong, including access to effective treatments and socioeconomic and cultural factors.  

Further resources

https://ga2len-ucare.com/

https://ga2len-ucare.com/levelup-educational-program/

https://ucare-4u.com/en/home-en/

https://cruse-control.com/

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Clinical review: The suggested management pathway for urticaria in primary care

Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

https://chronic-angioedema-registry.com/

https://acare-network.com/

Neuro–immuno–psychological aspects of chronic urticaria

Expression of hypothalamic–pituitary–adrenal axis in common skin diseases: Evidence of its association with stress-related disease activity

Psychological stress and chronic urticaria: A neuro-immuno-cutaneous crosstalk. A Systematic review of the existing evidence

Exaggerated neurophysiological responses to stressor in patients with chronic spontaneous urticaria

Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients

High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria

Triggers, risk factors and clinico-pathological features of urticaria in dogs – a prospective observational study of 24 cases

Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology

Immunology nursing competency framework

Sponsored: When is a swelling not an allergy?

Hong Kong–Macau severe hives and angioedema referral pathway

Disparities in chronic spontaneous urticaria: Eligibility for drug reimbursement associated with clinical outcomes

Chronic spontaneous urticaria in Hong Kong: Clinical characteristics, real-world practice and implications for COVID-19 vaccination

Who cares? UCARE

Episode 1 – As of September 2020, there are 110 certified UCARE centres spanning a total of 38 countries around the world. In this episode, Professor Marcus Maurer is joined by UCARE cofounder Dr Ana Giménez-Arnau to discuss the history of the UCARE network and offer practical advice to those seeking to become a member.

All things angioedema

Episode 10 – Angioedema expert and Angioedema Centers of Reference and Excellence (ACARE) founding father, Professor Markus Magerl, joins Professor Marcus Maurer to discuss all things angioedema and get the latest on the ever-growing ACARE network.

COLD-CE: Insights from a UCARE project

Episode 14 – Since its inception in 2018, COLD-CE has collected data on hundreds of patients with cold urticaria from around the world. In this episode, Dr Mojca Bizjak reflects on her experience of running a UCARE project, offering insight and advice for those hoping to do so in the future.

All things UCARE

Episode 15 – For those just starting out on their UCARE journey, the extensive list of criteria can seem daunting. In this episode, Professor Marcus Maurer is joined by Professor Kanokvalai Kulthanan, who offers her advice on tackling the application process.

All things ACARE

Episode 26 – Are you familiar with ACARE? Professor Marcus Maurer is joined by Dr Anete Grumach to celebrate the recent successes of the ACARE network and discuss the future of this exciting initiative.

UCARE LevelUp

Episode 32 – Dr Iman Nasr discusses UCARE LevelUp, an educational programme devised by the UCARE network to allow healthcare professionals to learn, network and share best clinical practices in CU. Dr Nasr also touches on UCARE 4U, the UCARE patient information and education platform and programme.

UCARE behind the scenes special (Part 1)

Episode 37 – In this special two-part episode, Professor Marcus Maurer is joined by four of his UCARE office colleagues to give listeners exclusive insight into the inner workings of the UCARE network, including advice on how to become a UCARE centre and updates on exciting new UCARE initiatives.

UCARE behind the scenes special (Part 2)

Episode 38 – In part two of this special episode, Professor Marcus Maurer is joined once again by his colleagues from the UCARE office to discuss the UCARE LevelUp and UCARE 4U programmes, which aim to inform and educate patients and physicians on the management of CU. To find out more information on UCARE, please visit ga2len-ucare.com.

CSU: Never give up

Episode 51 – Professor Silvia Ferrucci joins Professor Marcus Maurer in discussing what the phrase ‘never give up’ means to physicians treating urticaria, and for patients embarking on their treatment journey. Areas of special focus are given to guideline treatment algorithms and the implementation of the CRUSE app and Chronic Urticaria Registry (CURE) as tools to shift the balance of treating urticaria.

The importance of the chronic urticaria registry (CURE)

Episode 57 – Dr Pavel Kolkhir joins Professor Marcus Maurer to discuss CURE, including explanations of the aims of CURE in collecting quality, real-life data on chronic urticaria patient characteristics, the course of disease, underlying causes, comorbidities, treatment responses, quality of life impairment and healthcare costs.

Chronic Angioedema Registry (CARE)

Episode 83 – “I think CARE will grow and grow.” Dr Thomas Buttgereit joins Professor Marcus Maurer to discuss the recently launched Chronic Angioedema Registry (CARE), including benefits for patients, current capabilities and how to get involved.

Further resources

Chronic Angioedema Registry

The guideline guru

Episode 6 – With the sixth consensus meeting on the EAACI/GA2LEN/EDF/WAO guideline for urticaria fast approaching, Professor Marcus Maurer is joined by Professor Torsten Zuberbier, who explains what you can expect from this new edition.

Unanswered questions in CSU

Episode 19 – Professor Marcus Maurer is joined by UK-based dermatologist Dr Clive Grattan to address some of the most important unanswered questions in the field of CSU.

Paediatric urticaria: Current practice and future prospects

Episode 33 – Dr Vicky Xepapadaki joins the podcast to share her knowledge of paediatric urticaria, including current treatment strategies and unmet needs. Dr Xepapadaki also reflects on the importance of involving parents in clinical decision-making and highlights some of the key differences between adult and paediatric patients.

Improving urticaria education: An international perspective

Episode 34 – Dr Désirée Larenas-Linnemann joins our host to discuss the importance of providing better education on urticaria for patients and physicians around the world. Dr Larenas-Linnemann also highlights international differences in educational needs and the role of UCARE programmes in addressing these.

Audience proposed question: Guidance for potential treatments of CSU

Episode 65 – Professor Martin Metz joins Professor Marcus Maurer to answer an audience proposed question focusing on what will guide physicians in the recommendations for individual patients to identify the most beneficial treatment option to treat chronic spontaneous and inducible urticaria. Both experts delve into the current treatment options available, and treatments that are currently in clinical trials.

Angioedema and artificial intelligence

Episode 67 – Professor Markus Magerl joins Professor Marcus Maurer to explore the significance of differential diagnosis in the identification of angioedema in CSU. Professor Magerl takes a deep dive into the prospective use of artificial intelligence (AI) in the analysis of data derived from a questionnaire utilising algorithmic models. Maurer and Magerl reflect on the implications AI could have in enhancing the diagnostic accuracy of angioedema.

Urticaria management in resource-poor settings

Episode 70 – Dr Désirée Larenas-Linnemann and Professor Marcus Maurer delve into best practices for urticaria management in resource-poor settings, underlining the crucial role of accurate diagnosis and adherence to established guidelines. They also address trending topics in angioedema and urticaria treatment, such as antihistamine up-dosing and the complexities surrounding triple-combination therapies and the need for better education.

Histamine, antihistamines, and the future of urticariology

Episode 8 – Professor Martin Church reflects on the enormous progress that has been made in the field of urticariology and discusses what is yet to come for people with this disease.

Not just small adults: Managing paediatric CSU

Episode 20 – Professor Marcus Maurer is joined by Dr Moshe Ben-Shoshan, who shares his pioneering approach to treating paediatric patients and draws on his experience to debunk some of the common myths surrounding childhood urticaria.

What’s new in CSU?

Episode 22 – Dr Young-Min Ye shares the findings from her cutting-edge research into predictors of remission in CU and explains what is currently known about the role of Mas-related G protein-coupled receptor-X2 (MRGPRX2) in the activation of mast cells.

The truth about T cells

Episode 23 – Could targeting cytokines produced by autoreactive T cells benefit people with CSU? Professor Marcus Maurer is joined by Professor Elias Toubi to discuss the role of T cells in this disease.

Communication technology meets urticariology

Episode 24 – Professor Marcus Maurer is joined by Dr Ivan Chérrez Ojeda, an urticariologist and communication technology enthusiast, to discuss the potential application of telemedicine in the management of CU.

All things urticaria: COVID-19 vaccinations

Episode 44 – Professor Emek Kocatürk joins Professor Marcus Maurer to discuss the effects of the COVID-19 pandemic on people with CSU, and how COVID-19 vaccines impacted the exasperation of CSU as part of the COVAC-CU study.

The development of treating urticaria over the last 2 decades

Episode 50 – Professor Marcus Maurer is joined by Professor Luis Felipe Ensina to discuss the founding days of urticaria treatment and how urticaria clinics became available. Professor Maurer and Professor Ensina discuss how the treatment landscape, diagnostic techniques and further developments in the advancement of how clinicians treat people with urticaria have evolved over the last 2 decades.

Drug survivability of omalizumab in chronic urticaria

Episode 52 – Dr Heike Röckmann, head of the drug survivability of omalizumab in CU (DruSO-CU) project, joins Professor Marcus Maurer to discuss the global project, the difficulties encountered and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.

Bruton’s tyrosine kinase inhibitors in the treatment of CSU

Episode 61 – Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals with CSU. The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion on alternative treatments.

The role of angioedema in the treatment of CSU

Episode 62 – Professor Marcus Maurer is accompanied by Professor Marc Riedl to delve into the symptomatology and pathophysiology of angioedema in CSU. The mechanistic aetiology of angioedema within the context of CSU pathology is also explored. Professor Marc Riedl examines therapeutic treatments for patients concurrently experiencing angioedema in CSU while exploring how the characterisation of autoimmune and auto-allergic pathophysiological mechanisms can impact treatment decisions.

Soluble IgE receptor in urticaria

Episode 63 – Professor Marcus Maurer asks Dr Sherezade Moñino-Romero about her research into soluble IgE receptor and its potential as a marker of treatment response in CU. They also discuss the art of communicating science to the public and why it is so vital to do it effectively.

Non-steroidal anti-inflammatory drugs in CSU

Episode 74 – Professor Riccardo Asero joins Professor Marcus Maurer to offer advice on the use of non-steroidal anti-inflammatory (NSAID) drugs in people with CSU. The experts discuss risk assessment and strategies to avoid respiratory and cutaneous hypersensitivity reactions in people who require these common medications to manage comorbidities.

Antihistamines and urticaria

Episode 77 – “We treat until it’s gone.” Professor Marcus Maurer is joined by Professor Gordon Sussman to discuss the use of antihistamines in people with urticaria, covering the history, side effects, safety and best practices.

Does country make a difference?

Episode 84 – “This is a global problem that requires global solutions, but I think they do come from what we learn in our settings.” Professor Marcus Maurer welcomes Dr Clive Grattan to discuss the differences in the treatment and management of urticaria across the UK and Germany, including guideline recommendations and new treatments on the horizon.

How can we educate dermatologists on urticaria?

Episode 85 – Dr Jason Hawkes joins Professor Marcus Maurer to discuss dermatologists’ lack of urticaria knowledge, including tips on encouraging the US dermatology community to use resources such as the CRUSE app.

Further resources

10 Questions - Using AI for diagnosing your or your patient´s angioedema

Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell–mediated angioedema

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Consensus on treatment goals in hereditary angioedema: A global Delphi initiative

Positive basophil tests are linked to high disease activity and other features of autoimmune chronic spontaneous urticaria: A systematic review

Total IgE as a marker for chronic spontaneous urticaria

Soluble IgE-binding factors in the serum of food-allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor

https://sherezademr.com/

https://www.twitch.tv/sherezademr

https://twitter.com/sherezade_mr

https://www.tiktok.com/@sherezademr

https://www.youtube.com/@sherezademr

Nonsteroidal anti-inflammatory drugs hypersensitivity in chronic spontaneous urticaria in the light of its pathogenesis

Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria

British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021

Key messages: Urticaria guidelines

Urticaria: A comprehensive review

Hives: Diagnosis and treatment

Welcome: